東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁 到查詢結果 [ subject:"Cancer cells." ]

切換: 標籤 | MARC模式 | ISBD

Tumor organoids

Soker, Shay.

FindBook

Google Book

Amazon

博客來

Tumor organoids

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Tumor organoids/ edited by Shay Soker, Aleksander Skardal.
其他作者:	Soker, Shay.
出版者:	Cham :Springer International Publishing : : 2018.,
面頁冊數:	xvi, 213 p. :ill., digital ;24 cm.
內容註:	Techniques to Produce and Culture Lung Tumor Organoids -- Tissue Organoids: Liver -- Mammary Gland Organoids -- Biofabrication Technologies for Developing In Vitro Tumor Models -- Three Dimensional In Vitro Tumor Platforms for Cancer Discovery -- Tissue-engineered models for studies of bone metastasis -- Building Better Tumor Models: Organoid Systems to Investigate Angiogenesis -- Microfluidics in cell and tissue studies -- Stiffness-tuned matrices for tumor cell studies -- Mathematical modeling of tumor organoids: toward personalized medicine.
Contained By:	Springer eBooks
標題:	Cancer cells. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-60511-1
ISBN:	9783319605111

Tumor organoids
Tumor organoids[electronic resource] /edited by Shay Soker, Aleksander Skardal. - Cham :Springer International Publishing :2018. - xvi, 213 p. :ill., digital ;24 cm. - Cancer drug discovery and development,2196-9906. - Cancer drug discovery and development..

Techniques to Produce and Culture Lung Tumor Organoids -- Tissue Organoids: Liver -- Mammary Gland Organoids -- Biofabrication Technologies for Developing In Vitro Tumor Models -- Three Dimensional In Vitro Tumor Platforms for Cancer Discovery -- Tissue-engineered models for studies of bone metastasis -- Building Better Tumor Models: Organoid Systems to Investigate Angiogenesis -- Microfluidics in cell and tissue studies -- Stiffness-tuned matrices for tumor cell studies -- Mathematical modeling of tumor organoids: toward personalized medicine.

Cancer cell biology research in general, and anti-cancer drug development specifically, still relies on standard cell culture techniques that place the cells in an unnatural environment. As a consequence, growing tumor cells in plastic dishes places a selective pressure that substantially alters their original molecular and phenotypic properties.The emerging field of regenerative medicine has developed bioengineered tissue platforms that can better mimic the structure and cellular heterogeneity of in vivo tissue, and are suitable for tumor bioengineering research. Microengineering technologies have resulted in advanced methods for creating and culturing 3-D human tissue. By encapsulating the respective cell type or combining several cell types to form tissues, these model organs can be viable for longer periods of time and are cultured to develop functional properties similar to native tissues. This approach recapitulates the dynamic role of cell-cell, cell-ECM, and mechanical interactions inside the tumor. Further incorporation of cells representative of the tumor stroma, such as endothelial cells (EC) and tumor fibroblasts, can mimic the in vivo tumor microenvironment. Collectively, bioengineered tumors create an important resource for the in vitro study of tumor growth in 3D including tumor biomechanics and the effects of anti-cancer drugs on 3D tumor tissue. These technologies have the potential to overcome current limitations to genetic and histological tumor classification and development of personalized therapies.

ISBN: 9783319605111

Standard No.: 10.1007/978-3-319-60511-1doiSubjects--Topical Terms:

661301
Cancer cells.

LC Class. No.: RC269

Dewey Class. No.: 616.99407

Tumor organoids
LDR:03063nmm a2200325 a 4500 001 2131823
003 DE-He213
005 20180622142809.0
006 m d
007 cr nn 008maaau
008 181005s2018 gw s 0 eng d
020 $a 9783319605111 $q (electronic bk.)
020 $a 9783319605098 $q (paper)
024 7 $a 10.1007/978-3-319-60511-1 $2 doi
035 $a 978-3-319-60511-1
040 $a GP $c GP
041 0 $a eng
050 4 $a RC269
072 7 $a MJCL $2 bicssc
072 7 $a MED062000 $2 bisacsh
082 0 4 $a 616.99407 $2 23
090 $a RC269 $b .T925 2018
245 0 0 $a Tumor organoids $h [electronic resource] / $c edited by Shay Soker, Aleksander Skardal.
260 $a Cham : $b Springer International Publishing : $b Imprint: Humana Press, $c 2018.
300 $a xvi, 213 p. : $b ill., digital ; $c 24 cm.
490 1 $a Cancer drug discovery and development, $x 2196-9906
505 0 $a Techniques to Produce and Culture Lung Tumor Organoids -- Tissue Organoids: Liver -- Mammary Gland Organoids -- Biofabrication Technologies for Developing In Vitro Tumor Models -- Three Dimensional In Vitro Tumor Platforms for Cancer Discovery -- Tissue-engineered models for studies of bone metastasis -- Building Better Tumor Models: Organoid Systems to Investigate Angiogenesis -- Microfluidics in cell and tissue studies -- Stiffness-tuned matrices for tumor cell studies -- Mathematical modeling of tumor organoids: toward personalized medicine.
520 $a Cancer cell biology research in general, and anti-cancer drug development specifically, still relies on standard cell culture techniques that place the cells in an unnatural environment. As a consequence, growing tumor cells in plastic dishes places a selective pressure that substantially alters their original molecular and phenotypic properties.The emerging field of regenerative medicine has developed bioengineered tissue platforms that can better mimic the structure and cellular heterogeneity of in vivo tissue, and are suitable for tumor bioengineering research. Microengineering technologies have resulted in advanced methods for creating and culturing 3-D human tissue. By encapsulating the respective cell type or combining several cell types to form tissues, these model organs can be viable for longer periods of time and are cultured to develop functional properties similar to native tissues. This approach recapitulates the dynamic role of cell-cell, cell-ECM, and mechanical interactions inside the tumor. Further incorporation of cells representative of the tumor stroma, such as endothelial cells (EC) and tumor fibroblasts, can mimic the in vivo tumor microenvironment. Collectively, bioengineered tumors create an important resource for the in vitro study of tumor growth in 3D including tumor biomechanics and the effects of anti-cancer drugs on 3D tumor tissue. These technologies have the potential to overcome current limitations to genetic and histological tumor classification and development of personalized therapies.
650 0 $a Cancer cells. $3 661301
650 0 $a Cancer $x Molecular aspects. $3 661419
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Cancer Research. $3 891172
700 1 $a Soker, Shay. $3 3297774
700 1 $a Skardal, Aleksander. $3 1683894
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Cancer drug discovery and development. $3 1565408
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-60511-1
950 $a Medicine (Springer-11650)